global kidney cancer drugs market 2015-2019
TRANSCRIPT
USA – CANADA – UK – CHINA – INDIA
Global Kidney Cancer Drugs Market 2015-2019
The report discusses the following in-depth:
• Market Size and Forecast
• Market Segmentation
• Buying Criteria
• Vendor Landscape
• Business Segmentation
• Geographical Segmentation
For more information on the
Global Kidney Cancer Drugs Market 2015-2019,
please mail us [email protected]
USA – CANADA – UK – CHINA – INDIA
Key Trends
Technavio’s Senior Analyst says, “The sedentary lifestyle of individuals resulting in obesity and hypertension leads to kidney cancer. The growing number of individuals with kidney cancer results in the increased use of drugs for disease treatment. Initiatives by regulatory authorities and vendors in the development of new treatment options also propel market growth.”
• Kidney cancer also known as renal cancer affects the kidney cells. RCC is the most common form of kidney cancer in adults and Wilms' tumor in children. The exact cause of the disease is not yet known. The symptoms of renal cancer are often confused with other kidney disorders.
• Technavio's analysts forecast the global kidney cancer drugs market to grow at a CAGR of 7.36% over the period 2014-2019.
• Understanding the key drivers influencing the market
• Understanding the challenges faced by the market
• Activities of various stakeholders involved
• Key focus areas for the vendors
• Major trends that will shape the future of this market
• Vendor landscape and trajectory of the market
• Conclusion
Scope of The Report
A detailed analysis of each market driver, challenge
and trend isavailable in our report:
Global Kidney Cancer Drugs Market 2015-2019
USA – CANADA – UK – CHINA – INDIA
USA – CANADA – UK – CHINA – INDIA
Vendors
To understand the vendor landscape and for a full list of vendors view our
report:
Global Kidney Cancer Drugs Market 2015-2019
Bayer
F. Hoffmann-La Roche
GlaxoSmithKline
Bayer was founded in 1863 and is headquartered in Leverkusen, Germany. It develops, produces, and markets healthcare and agricultural products and high-tech polymer materials.
F. Hoffmann-La Roche, a subsidiary of Roche Holding AG, is a healthcare company that undertakes discovery, development, manufacturing, and marketing of innovative diagnostic and therapeutic products and services.
GlaxoSmithKline was incorporated in 1999 as a result of the merger between Glaxo Wellcome and SmithKline Beecham. The company is headquartered in Brentford, Middlesex, UK. It develops, manufactures, and markets pharmaceutical products worldwide.
USA – CANADA – UK – CHINA – INDIA
Market Landscape
• The global kidney cancer drugs market is expected to grow rapidly during the forecast period because of the constant development of drugs for kidney cancer using innovative technologies.
• Currently, many new drugs are in various developmental stages.
• The population of individuals with kidney cancer has increased, which has a positive impact on market growth.
• Many companies are developing vaccines for the treatment of kidney cancer. The most recent advance in kidney cancer treatment has been the use of cell therapies.
• Vendors are using various technologies, such as Arcelis technology and 5T4 tumor antigen platform to develop advanced medications for the treatment of renal cancer.
• The provision of orphan drug designation and fast track designation for medications also propels market growth.
USA – CANADA – UK – CHINA – INDIA
Key Buying Criteria
• Authenticity • Delivery • Price• Service
Support
Parameter Details
Efficacy Drugs used to treat kidney cancer should be efficient and show positive results.
Availability Drugs used to treat kidney cancer should be readily available.
Affordability Drugs used to treat kidney cancer should be reasonably priced.
Safety Drugs used to treat kidney cancer should be safe and have minimal side effects.
• Growth Forecasts?
• Market Analysis?
• Revenue Forecasts?
• Regional and Country level Analysis?
• Competitive Structure?
• Emerging Trends?
• Vendor Landscape?
• Other?
What Would You Like to Learn From Technavio?
Global Kidney Cancer Drugs Market 2015-2019
Let us identify your needs.We would love to hear more!
USA – CANADA – UK – CHINA – INDIA
Our Report Covers: Market Scenarios, Vendor landscape & Industry Road Maps.
You have the Option to Customize Reports & Access Analysts on every Report Purchase.
Purchasing this report?
For media enquiries,please drop us a mail at
We’ll include an hour with our analysts to discuss the report findings.
For free.
USA – CANADA – UK – CHINA – INDIA
Access the Report
USA – CANADA – UK – CHINA – INDIA
India: An Overview
USA – CANADA – UK – CHINA – INDIA
About Us
USA – CANADA – UK – CHINA – INDIA
Thank You!
North America
Chicago, USA
Phone: +1 630 333 9501
Fax: +1 630 833 2171
Europe
London, United Kingdom
Phone: +44 208 123 1770
Fax: +44 845 280 2825
Asia
Bangalore, India
Phone: +91 934 254 0560
Fax: +91 80 4080 6070
DISCLAIMER
This presentation is intended solely for showcasing Infiniti’s research capabilities. All information contained within this presentation has been randomized and should not be used for any kind of analysis and/or for decision making purpose. All trademarks and copyrights remain the sole ownership of their rightful owners/licensees. In no event shall
Infiniti Research have any liability to any party for special, incidental, tort, or consequential damages arising out of or in connection with this report, even if Infiniti Research has been advised of the possibility of such damages.
Copyright ©2013 Infiniti Research Limited. All Rights Reserved.
Reproduction without written permission is completely forbidden.
NOT FOR FURTHER DISTRIBUTION